About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Cemdisiran (Cemdisiran)

-

-

-

[6] 11, 15, 62, 66, 109, 223 💬

Disease ID	Name
11	Myasthenia gravis
15	Inclusion body myositis
62	Paroxysmal nocturnal hemoglobinuria
66	IgA nephropathy
109	Atypical hemolytic uremic syndrome
223	Primary membranoproliferative glomerulonephritis

2

Combination Product: Pozelimab/Cemdisiran

[2] Cemdisiran (Cemdisiran),
Pozelimab

[1] Pozelimab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[1] 15 💬

3

Pozelimab + Cemdisiran

[2] Cemdisiran (Cemdisiran),
Pozelimab

[1] Pozelimab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[1] 11 💬